# Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

> **NCT00227227** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 750 (estimated)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00227227
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2007-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227227, "Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00227227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*